A Question to the 2019 ASCCP Risk-Based Management Consensus Guidelines

Comment

Yunfeng Fu et al. J Low Genit Tract Dis. 2020 Oct.

. 2020 Oct;24(4):425.

doi: 10.1097/LGT.0000000000000561.

No abstract available

Comment in

Response to Letter to the Editor Regarding: 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors.
Perkins RB, Guido RL, Castle PE, Chelmow D, Einstein MH, Garcia F, Huh WK, Kim JJ, Moscicki AB, Nayar R, Saraiya M, Sawaya G, Wentzensen N, Schiffman M. Perkins RB, et al. J Low Genit Tract Dis. 2020 Oct;24(4):426. doi: 10.1097/LGT.0000000000000562. J Low Genit Tract Dis. 2020. PMID: 32732648 No abstract available.

2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors.
Perkins RB, Guido RS, Castle PE, Chelmow D, Einstein MH, Garcia F, Huh WK, Kim JJ, Moscicki AB, Nayar R, Saraiya M, Sawaya GF, Wentzensen N, Schiffman M; 2019 ASCCP Risk-Based Management Consensus Guidelines Committee. Perkins RB, et al. J Low Genit Tract Dis. 2020 Apr;24(2):102-131. doi: 10.1097/LGT.0000000000000525. J Low Genit Tract Dis. 2020. PMID: 32243307 Free PMC article. No abstract available.

1. Perkins RB, Guido RS, Castle PE, et al. 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors. J Low Genit Tract Dis 2020;24:102–31.